Bob Bennett
The Public Record
Bob Bennett is a former Republican U.S. Senator from Utah, who served from 1993 to 2011. He was the first Utah senator to be elected to three consecutive terms. During his time in office, Bennett was known for his moderate stance on various issues, including healthcare and fiscal responsibility. He played a significant role in the Senate Appropriations Committee and was involved in efforts to reform the U.S. healthcare system. Bennett was defeated in the 2010 Republican primary, which marked the end of his political career in the Senate. He has remained active in political discussions and has contributed to various policy initiatives since leaving office.
I know a politician who used that phrase and maybe regretted it, but I will be appropriately admonished.
Any chance that this can mean lowering of mandatory payments, mandatory support payments to help us out with the budget?
Well, we will look at this closely. I note that the budget requests termination of the diet research and obesity research program at Pennington Biomedical Research Center at ARS headquarters and then requests funding for an Administration…
I would like to find a way to get that into discretionary funds. I am not sure we can.
Well, does that mean we no longer need to provide funding for diet, nutrition and obesity research at the Pennington Biomedical Research Center or Pierce's Disease research in California or Sudden Oak Disease research in Maryland?
If Congress were to agree to these terminations, we calculate 312 ARS scientists, researchers and support staff in 42 States would lose their jobs.
Yes, yes; well, okay, if the program becomes an open-ended entitlement, as some have suggested, do you have any estimate of the cost?
I would just hope, and it does not appear, that the controlling factor as to which projects get terminated and which ones do not is which ones came from the Congress and which ones did not.
I would appreciate it if you would furnish to the Committee information about the supercomputing resources.
We have talked to you about the pyramid. I seemed to get a lot of publicity the last time I did that.
Yes, yes; well, okay, if the program becomes an open-ended entitlement, as some have suggested, do you have any estimate of the cost?
Please explain your fiscal year 2004 calculations and provide us with documented information that explains the discrepancy between your original and current calculations.
I will do everything possible to ensure they get a fair deal and are well-represented as Congress considers such important issues.
Is 100-percent testing of the export market physically possible? Is that a feasible thing?
wouldn't everybody be better off if there was an open, transparent, and science-driven process before the FDA announces its conclusions?
If Congress were to agree to these terminations, we calculate 312 ARS scientists, researchers and support staff in 42 States would lose their jobs.
We do not think that is the prudent thing to do, to test 100 percent for BSE.
Any chance that this can mean lowering of mandatory payments, mandatory support payments to help us out with the budget?





